期刊
REVISTA IBEROAMERICANA DE MICOLOGIA
卷 30, 期 3, 页码 209-212出版社
ASOCIACION ESPANOLA MICOLOGIA-AEM
DOI: 10.1016/j.riam.2013.01.001
关键词
Drug resistance; Mutation; Candida; ERG11 gene; Fluconazole
类别
资金
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
Background: For many years fluconazole has been commonly used to treat Candida infections. However, the indiscriminate use of this antimycotic therapy has favored the emergence of resistant isolates. Mutations in the ERG11 gene have been described as one of the primary mechanisms of resistance in Candida species. Aims: In this study we investigated missense mutations in ERG11 genes of Candida albicans, Candida glabrata and Candida tropicalis isolates previously evaluated by susceptibility testing to fluconazole. Methods: Screening for these mutations was performed on 19 Candida clinical isolates (eight C. albicans, five C. glabrata and six C. tropicalis) resistant and susceptible to fluconazole. The ERG11 gene was amplified by PCR with specific primers for each Candida species and analyzed by automated sequencing. Results: We identified 14 different missense mutations, five of which had not been described previously. Among them, a new mutation L321F was identified in a fluconazole resistant C. albicans isolate and it was analyzed by a theoretical three-dimensional structure of the ERG11p. Conclusion: The L321F mutation in C. albicans ERG11 gene may be associated with fluconazole resistance. (c) 2012 Revista lberoamericana de Micologia. Published by Elsevier Espana, S.L. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据